Welcome To Biovotec.
Biovotec's products are positioned to rapidly become the preferred solution in the market for hard-to-heal and chronic wounds.
Biovotec is currently undertaking clinical trials in the UK for our lead product, DermaRep™.
DermaRep™ has the potential to offer unrivalled cost-efficiency for both hospitals and society at large.
Our mission is to make advanced wound care treatment affordable and available for everybody, from the moment they need it.
Biovotec certified ISO 13485:2016 & EN ISO13485:2016